TheraSense Launches First Built-In PDA-Based Glucose Monitor

TheraSense Launches First Built-In PDA-Based Glucose Monitor

40
0
SHARE

TheraSense, Inc. a leader in blood glucose monitoring and maker of the popular, virtually pain-free FreeStyle(TM) system, announced today it has received FDA clearance to market the FreeStyle Tracker(TM) Diabetes Management System, a first-of-its-kind glucose monitoring system that is integrated into a personal digital assistant (PDA). Available for use with the Handspring(TM) Visor(TM) PDA, the new diabetes monitoring and management tool enables patients to test for glucose levels and get a read-out on the PDA screen, graph and chart the results over time, review carbohydrate food lists to track their food intake, create reminders about testing or dietary choices, and more. For doctors, the FreeStyle Tracker System provides a highly accurate time stamped progression of the patient’s glucose levels as well as patient-entered events and data that affect their diabetic health to make better diagnoses and recommendations for the patient’s diabetes care.

“We incorporated the blood glucose monitoring technology from our popular FreeStyle monitor into a module for the Handspring Visor PDA,” said Mark Lortz, president and CEO of TheraSense. “You get the accuracy, alternate site testing capability and the world’s smallest sample size of our virtually pain-free FreeStyle system combined with sophisticated diabetes management tools integrated into a PDA. Our hope is that FreeStyle Tracker will reduce the pain of diabetes management much like the FreeStyle system reduced the pain of glucose testing.”

The FreeStyle Tracker System, will be sold in two configurations, with and without a Visor PDA. Both product versions will be available at www.therasense.com by June 14, 2002. Orders and inquiries can also be directed to TheraSense at 888-522-5226. TheraSense expects to offer the FreeStyle Tracker System through some of its national chain drug store partners and medical supply networks in the coming months.

LEAVE A REPLY